Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy

Eur J Surg Oncol. 2009 Apr;35(4):380-6. doi: 10.1016/j.ejso.2008.07.009. Epub 2008 Aug 30.

Abstract

Aims: Minimal access breast surgery (MABS) is a procedure that completes breast conservation surgery (BCS) and sentinel node biopsy (SNB) through a single incision. It allows access to axillary sentinel nodes via the breast incision and also provides access to the internal mammary nodes (IMN) as well as other nodal sites when needed. The aims of this study are to describe the MABS approach and to evaluate its safety and efficacy in cases undergoing BCS and SNB (axillary or IMN) for treatment of breast cancer.

Methods: The surgical technique for MABS is described. One hundred and three consecutive clinically lymph node negative patients undergoing BCS and SNB (axillary or IMN) were considered for MABS. Cases were classified according to the location of sentinel nodes dissected (axillary, internal mammary or other), the location of the tumour and whether MABS was used. The success of MABS was calculated based on the number of cases where BCS and SNB were completed through a single breast incision. Number of lymph nodes (LN) retrieved, rate of LN positivity, aesthetics and complications were documented.

Results: Eighty-six percent of cases of BCS with axillary-only SNB were completed with MABS. For cases of BCS with axillary and IMN SNB, MABS was successful for BCS and IMN SNB in 97% of cases and for BCS and SNB from both nodal regions in 63%. There was only one case, a woman with breast prostheses, who required three separate incisions. When axillary-only SNB cases were completed with MABS, an average of 2.9 axillary LN per case with a 29% axillary LN positivity rate was seen. When axillary and IMN SNB were completed with MABS for both regions, an average of 3.0 axillary LN per case were retrieved with an axillary LN positivity rate of 65%. When separate axillary and breast incisions were made, 2.7 LN per case were removed with an axillary LN positivity rate of 30%. Aesthetics were excellent and there were no complications associated with reaching the nodes through the breast incision.

Conclusion: MABS is a feasible option for the majority of women undergoing BCS and SNB and it does not compromise the success of SNB.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Axilla / surgery
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Esthetics
  • Feasibility Studies
  • Female
  • Humans
  • Lymph Node Excision / methods
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Mastectomy, Segmental*
  • Middle Aged
  • Sentinel Lymph Node Biopsy* / methods
  • Treatment Outcome
  • Young Adult